TAYLOR EVANS: Open Payments
NPI 1447983424 · UNIONTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,245 in 79 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $552 · 2025 $1,245
Food & beverage: $1,153Education: $92
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 17 | $315 |
| Regeneron Healthcare Solutions, Inc. | 7 | $271 |
| UCB, Inc. | 14 | $236 |
| ABBVIE INC. | 21 | $147 |
| MAYNE PHARMA COMMERCIAL LLC | 7 | $51 |
| LEO Pharma Inc. | 2 | $43 |
| Galderma Laboratories, L.P. | 2 | $41 |
| Amgen Inc. | 2 | $40 |
| Janssen Biotech, Inc. | 2 | $37 |
| Arcutis Biotherapeutics, Inc. | 2 | $30 |
Products named: DUPIXENT, Bimzelx, RINVOQ, SKYRIZI, NEMLUVIO, OTEZLA, TREMFYA, Zoryve.
Industry payments across PA — which companies pay providers there.
